{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:33:12Z","timestamp":1792359192550,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.amjmed.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T04:09:34Z","timestamp":1463976574000},"page":"635.e15-635.e26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-3737","authenticated-orcid":false,"given":"Parag","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid I.","family":"Almarzooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn M.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Karas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy N.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Minutello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Chiu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2016.02.007_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.02.007_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2016.02.007_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib4","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.02.007_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","article-title":"Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","article-title":"Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study","volume":"86","author":"Devereux","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","article-title":"Importance of heart failure with preserved systolic function in patients > or\u00a0= 65 years of age. CHS Research Group. Cardiovascular Health Study","volume":"87","author":"Kitzman","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A\u00a0contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.02.007_bib11","author":"Healthcare Cost and Utilization Project (HCUP). HCUP Nationwide Inpatient Sample (NIS)","year":"2007"},{"key":"10.1016\/j.amjmed.2016.02.007_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.159","article-title":"The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%)","volume":"16","author":"Lam","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjmed.2016.02.007_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.amjmed.2016.02.007_bib14","unstructured":"US Census Bureau. Population estimates and demographic components of change by age, sex, race, & Hispanic origin for the United States, 2003. Available at: https:\/\/www.census.gov\/popest\/data\/state\/totals\/2003\/tables\/NST-EST2003-08.pdf. Accessed December 12, 2015."},{"key":"10.1016\/j.amjmed.2016.02.007_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jacc.2012.11.057","article-title":"National trends in heart failure hospital stay rates, 2001 to 2009","volume":"61","author":"Chen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1532-5415.1995.tb05570.x","article-title":"Heart failure with normal systolic function: a common disorder in older people","volume":"43","author":"Tresch","year":"1995","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2016.02.007_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2015.02.025","article-title":"Heart failure with preserved ejection fraction in the elderly: scope of the problem","volume":"83","author":"Upadhya","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib18","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2016.02.007_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2016.02.007_bib21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jacc.2008.01.028","article-title":"Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry","volume":"51","author":"Yancy","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.amjcard.2006.03.066","article-title":"Comparison of African-American patients with systolic heart failure versus preserved ejection fraction","volume":"98","author":"Ilksoy","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1370\/afm.873","article-title":"Racial disparity in hypertension control: tallying the death toll","volume":"6","author":"Fiscella","year":"2008","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1001\/archinte.165.18.2098","article-title":"Racial disparities in hypertension prevalence, awareness, and management","volume":"165","author":"Hertz","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCOUTCOMES.110.960112","article-title":"Racial differences in incident heart failure during antihypertensive therapy","volume":"4","author":"Okin","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2016.02.007_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.HYP.0000128738.94190.9f","article-title":"Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study","volume":"43","author":"Kizer","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.amjmed.2016.02.007_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjmed.2014.08.024","article-title":"Multimorbidity in heart failure: a community perspective","volume":"128","author":"Chamberlain","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2014.12.017","article-title":"The hospitalization burden and post-hospitalization mortality risk in heart failure with preserved ejection fraction: results from the I-PRESERVE trial (irbesartan in heart failure and preserved ejection fraction)","volume":"3","author":"Carson","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjmed.2016.02.007_bib30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.02.007_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00392-011-0305-4","article-title":"Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction","volume":"100","author":"Edelmann","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib33","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2016.02.007_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/eurjhf\/hfp103","article-title":"The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis","volume":"11","author":"Somaratne","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.amjmed.2016.02.007_bib35","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","author":"Meta-analysis Global Group in Chronic Heart Failure","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2016.02.007_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823","article-title":"Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives","volume":"7","author":"Guazzi","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjmed.2016.02.007_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study","volume":"6","author":"Smith","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2016.02.007_bib40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.02.007_bib41","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1345\/aph.1P372","article-title":"Pharmacologic management of heart failure with preserved ejection fraction","volume":"44","author":"Huang","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2016.02.007_bib42","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2010.748","article-title":"Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006","volume":"303","author":"Bueno","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2016.02.007_bib43","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.jacc.2015.03.518","article-title":"Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011","volume":"65","author":"Pant","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib44","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2012.07.017","article-title":"Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures","volume":"60","author":"Greenspon","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.02.007_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316301942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316301942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:08:00Z","timestamp":1757581680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934316301942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0002934316301942"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.02.007","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada","name":"copyright","label":"Copyright"}]}}